Crucial role of intracellular effectors on glycogenolysis in the isolated rat heart: Potential consequences on the myocardial tolerance to ischemia

Molecular and Cellular Biochemistry

Volumn 160-161, Issue , 1996, Pages 273-282

  Lavanchy, N ^a   Grably, S ^a   Garnier, A ^a   Rossi, A ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

AMP; Catecholamines; Glycogen; Intracellular effectors; Ischemia; Isolated heart; Pi

Indexed keywords

ADENOSINE PHOSPHATE; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; ISOPRENALINE; PHOSPHATE; PHOSPHORUS 31;

ACIDOSIS; ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL PH; CONTROLLED STUDY; ENERGY BALANCE; ENZYME ACTIVITY; FEMALE; GLYCOGENOLYSIS; HEART MUSCLE ISCHEMIA; ISOLATED HEART; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CYTOSOL; FEMALE; GLYCOGEN; HYDROGEN-ION CONCENTRATION; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PHOSPHATES; PHOSPHORYLASES; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0029814595     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00240059     Document Type: Article

References (63)

1. Wollenberger A, Shahab L: Anoxia-induced release of noradrenaline from the isolated perfused heart. Nature 207: 88-89, 1965
2. Wollenberger A, Krause EG, Shahab L: Endogenous catecholamine mobilization and the shift to an aerobic energy production in the acutely ischemic myocardium. In: G. Marchetti and B. Taccardi. Coronary circulation and energetics of the myocardium. Karger, Basel and New York, 1967, p 200
3. Shahab L, Wollenberger A: Freisetzung von Noradrenalin aus demisolierten durchströmten Herzen bei akute Anoxie und nach Gabe von Stoffwech selgiften. Acta Biol Med Germ 19: 939-959, 1967
4. Wollenberger A, Krause EG: Metabolic control characteristics of the acutely ischemic myocardium. Amer J Cardiol 22: 349-359, 1968
5. Wollenberger A, Krause EG, Heier G: Stimulation of 3′-5′-cyclic AMP formation in dog myocardium following arrest of blood flow. Biochem Biophys Res Commun 36: 664-670, 1969
6. Wolfe CL, Sievers RE, Visseren FLJ, Donnelly TJ: Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 87: 881-892, 1993
7. Schaefer S, Carr LJ, Prussel E, Ramasamy R: Effects of glycogen depletion on ischemic injury in isolated rat hearts: insights into preconditioning. Am J Physiol 268: H935-H944, 1995
8. Scheuer J, Stezoski SW: Protective role of increased myocardial glycogen stores in cardiac anoxia in the rat. Circ Res 27: 835-849, 1970
9. Hewitt RL, Lolley DM, Adrouny GA, Drapanas T: Protective effect of glycogen and glucose on the anoxic arrested heart. Surgery 75: 1-10, 1974
10. Towart R, Schlossmann K, Kazda S: Protection against cardiac anoxia- role and limitations of increased glycogen reserves in the isolated right ventricular strip. Basic Res Cardiol 76: 639-646, 1981
11. Lolley DM, Ray JF, Myers WO, Sautter RD, Tewksbury DA: Importance of preoperative myocardial glycogen levels in human cardiac preservation. J Thorac Cardiovasc Surg 78: 678-687, 1979
12. Bricknell OL, Daries DS, Opie LH: A relationship between adenosine triphosphate, glycolysis and ischaemic contracture in the isolated rat heart. J Mol Cell Cardiol 13: 941-945, 1981
13. Lagerstrom CF, Walker WE, Taegtmeyer H: Failure of glycogen depletion to improve left ventricular function of the rabbit heart after hypothermic ischemic arrest. Circ Res 63: 81-86, 1988
14. Neely JR, Grotyohann LW: Role of glycolytic products in damage to ischemic myocardium. Circ Res 55: 816-824, 1984
15. Gevers W: Generation of protons by metabolic processes in heart cells. J Mol Cell Cardiol 9: 867-874, 1977
16. Dennis SC, Gevers W, Opie LH: Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol 23: 1077-1086, 1991
17. Opie LH: Myocardial ischemia-metabolic pathways and implications of increased glycolysis. Cardiovasc Drugs and Therapy 4: 777-790, 1990
18. Owen P, Dennis S, Opie LH: Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res 66: 344-354, 1990
19. Fischer EH, Heilmeyer LMG, Haschke RH: Phosphorylase and the control of glycogen degradation. Curr Top Cell Regul 4: 211-251, 1971
20. Graves DJ, Wang JH: α-glucan phosphorylases-Chemical and physical basis of catalysis and control. In: P.D. Boyer (Ed.) The Enzymes. Academic 7, New York, 1972, pp 435-482
21. Krebs EG: Phosphorylation and dephosphorylation of glycogen phosphorylase: a prototype for reversible covalent modification. Curr Top Cell Regul 18: 401-419, 1981
22. Madsen NB: Glycogen phosphorylase. In: P.D. Boyer (Ed.) The Enzymes. Academic 17, New York, 1986, pp 365-394
23. Johnson LN: Glycogen phosphorylase: Control by phosphorylation and by allosteric effectors. FASEB J 6: 2274-2282, 1992
24. Fischer EH, Hurd S, Kon P, Seery YL, Teller DC: Phosphorylase: relation of structure to activity. In: W.J. Whelan (Ed.) Control of glycogen metabolism. Academic, London, 1968, pp 19-33
25. Hurd SS, Teller D, Fischer EH: Probable formation of partially phosphorylated intermediates in the interconversion of phosphorylase a and b. Biochem Biophys Res Commun 24: 79-84, 1966
26. Bot G, Kovacs EF, Gergely P: Partial phosphorylation of muscle phosphorylase. I. Formation of a hybrid phosphorylase in vitro. Biochem Biophys Acta 370: 70-77, 1974
27. Gergely P, Bot G, Kovacs EF: Partial phosphorylation of muscle phosphorylase. II. Formation of a hybrid phosphorylase in vivo. Biochem Biophys Acta 370: 78-84, 1974
28. Williams BJ, Mayer SE: Hormonal effects on glycogen metabolism in the rat heart in situ. Mol Pharmacol 2: 454-464, 1966
29. Mayer SE: Effect of catecholamines on cardiac metabolism. Circ Res (suppl to 34-35): 129-135, 1974
30. Morgan HE, Parmeggiani A: Regulation of glycogenolysis in muscle. II. Control of glycogen phosphorylase reaction in isolated perfused heart. J Biol Chem 239: 2434-2439, 1964
31. Morgan HE, Parmeggiani A: Regulation of glycogenolysis in muscle. III. Control of muscle glycogen phosphorylase activity. J Biol Chem 239: 2440-2445, 1964
32. 13C-NMR study on the isolated perfused rat heart. FEBS Letters 178: 34-38, 1984
33. Lavanchy N, Martin J, Rossi A: Graded global ischemia and reperfusion of the isolated perfused rat heart: Characterization by 31P-NMR spectroscopy of the extent of energy metabolism damage. Cardiovasc Res 18: 573-582, 1984
34. Bergmeyer HU, (Ed.) Methods of enzymatic analysis. Academic Press, New York, 1963
35. Eggleton P, Elsden SR, Gough N: Estimation of creatine and diacethyl. Biochem J 37: 526-529, 1943
36. Gilboe DP, Larson KL, Nuttal FQ: Radioactive method for the assay of glycogen phosphorylase. Anal Biochem 47: 20-27, 1972
37. Kauppinen RA, Hiltunen JK, Hassinen IE: Subcellular distribution of phosphogens in isolated perfused rat hearts. FEBS Lett 112: 273-276, 1980
38. Polimeni PI, Buraczewski SI: Expansion of extracellular tracer spaces in the isolated heart perfused with cristalloid solution: Expansion of extracellular space, transsarcolemmal leakage, or both. J Mol Cell Cardiol 20: 15-22, 1988
39. 2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. J Biol Chem 254: 6528-6537, 1979
40. Grably S, Rossi A: Changes in cardiac glycogen synthase and phosphorylase activities following stimulation of beta-adrenergic receptors in rats. Basic Res Cardiol 80: 175-181, 1985
41. Cornblath M, Randle AJ, Parmeggiani A, Morgan HE: Regulation of glycogenolysis in muscle. Effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart. J Biol Chem 238: 1592-1597, 1963
42. Oye I: The role of phosphorylase a and b for the control of glycogenolysis in the isolated working rat heart. Acta Physiol Scand 70: 229-235, 1967
43. Neely JR, Whitfield CF, Morgan HE: Regulation of glycogenolysis in hearts: effects of pressure development, glucose and FFA. Am J Physiol 219(4): 1083-1088, 1970
44. Dobson JG, Mayer SE: Mechanisms of activation of cardiac glycogen phosphorylase in ischemia and anoxia. Circ Res 33: 412-420, 1973
45. Nuttall FQ, Gannon MC, Bergstrom WJ: Insulin and epinephrine effects on heart glycogen synthase and phosphorylase activity. Am J Physiol 228: 1815-1820, 1975
46. Miller TB, Praderio M, Wolleben C, Bullman J: A hypersensitivity of glycogen phosphorylase activation in hearts of diabetic hearts. J Biol Chem 256: 1748-1753, 1981
47. Laughlin MR, Petit Jr. WA, Barrett J: The time course of myocardial glycogenolysis stimulated by glucagon. J Mol Cell Cardiol 25: 175-183, 1993
48. Wanson JC, Drochmans P: Role of the sarcoplasmic reticulum in glycogen metabolism. J Cell Biol 54: 206-224, 1972
49. Entman ML, Bornet EP, Van Winkle WB, Goldstein MA, Schwartz A: Association of glycogenolysis with cardiac sarcoplasmic reticulum. J Mol Cell Cardiol 9: 515-528, 1977
50. Schulze W, Krause EG, Wollenberger A: On the fate of glycogen phosphorylase in the ischemic and infarcting myocardium. J Mol Cell Cardiol 2: 241-251, 1971
51. Sakai K, Abiko Y: Acute changes of myocardial norepinephrine and glycogen phosphorylase in ischemic areas after coronary ligation in dogs. Jpn Circulation J 45: 1250-1255, 1981
52. Hough FS, Gevers W: Catecholamine release as mediator of intracellular activation in ischemic perfused rat hearts. South Afr Med J 49: 538-543, 1975
53. Podzuweit T, Dalby AJ, Cherry GW, Opie LH: Cyclic AMP levels in ischaemic and non-ischaemic myocardium following coronary artery ligation: relation to ventricular fibrillation. J Mol Cell Cardiol 10: 81-94, 1978
54. Carlsson L, Abrahamsson T, Almgren O: Local release of myocardial norepinephrine during acute ischemia: An experimental study in the isolated perfused rat heart. J Cardiovasc Pharmacol 7: 791-798, 1985
55. 31P NMR of the effects of acebutolol on the ischaemic isolated rat heart. Eur J Pharmacol 125: 341-351, 1986
56. Lavanchy N, Martin J, Rossi A: The role of beta-adrenoceptors in ischemia induced acidosis in the isolated rat heart: a 31-P NMR study in. In N.J. Dhalla, I.R. Innei and R.E. Beamish, (Eds). 'Myocardial ischemia,' Martinus Nijhoff Publishing, Boston, Dordrecht, Lancaster, 1987, pp 199-212
57. Drummond GI, Duncan L: The action of calcium ion on cardiac phosphorylase b kinase. J Biol Chem 241: 3097-3103, 1966
58. Dobson JG, Ross J, Mayer SE: The role of cyclic adenosine 3′-5′ monophosphate and calcium in the regulation of contractility and glycogen phosphorylase activity in guinea pig papillary muscle. Circulation Res 39: 388-395, 1976
59. Parmeggiani A, Morgan HE: Effects of adenine nucleotides and inorganic phosphate on muscle phosphorylase activity. Biochem Biophys Res Commun 9: 252-256, 1962
60. Garlick PB, Radda GK, Seeley PJ: Studies of acidosis in the ischaemic heart by phosphorus nuclear magnetic resonance. Biochem J 184: 547-554, 1979
61. Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura I, Yabuuchi Y.: Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 84: 2495-2503, 1991
62. De Albuquerque CP, Gerstenblith G, Weiss RG: Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ Res 74: 139-150, 1994
63. Kupriyanov VV, Lakomkin VL, Steinschneider AY, Severina MY, Kapelko VI, Ruuge EK, Saks VA: Relationships between pre-ischemic ATP and glycogen content and post-ischemic recovery of rat heart. J Mol Cell Cardiol 20: 1152-1162, 1988